NPI: 1467499558 · MEMPHIS, TN 38116 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/31/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 05/31/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,740 | $155K |
| 2019 | 6,818 | $109K |
| 2020 | 1,491 | $59K |
| 2021 | 314 | $16K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 7,514 | 582 | $338K |
| 85048 | 179 | 165 | $0.00 | |
| 83970 | 220 | 198 | $0.00 | |
| 83540 | 88 | 87 | $0.00 | |
| 85041 | 180 | 165 | $0.00 | |
| 85045 | 25 | 24 | $0.00 | |
| 82108 | 12 | 12 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 2,892 | 209 | $0.00 |
| A4657 | Syringe, with or without needle, each | 307 | 299 | $0.00 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 2,722 | 140 | $0.00 |
| 83550 | 76 | 75 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 12 | 12 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 12 | 12 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 35 | 12 | $0.00 |
| 82728 | 89 | 88 | $0.00 |